Patents Assigned to Regents, University of California
  • Patent number: 6262523
    Abstract: Large area atmospheric-pressure plasma jet. A plasma discharge that can be operated at atmospheric pressure and near room temperature using 13.56 MHz rf power is described. Unlike plasma torches, the discharge produces a gas-phase effluent no hotter than 250° C. at an applied power of about 300 W, and shows distinct non-thermal characteristics. In the simplest design, two planar, parallel electrodes are employed to generate a plasma in the volume therebetween. A “jet” of long-lived metastable and reactive species that are capable of rapidly cleaning or etching metals and other materials is generated which extends up to 8 in. beyond the open end of the electrodes. Films and coatings may also be removed by these species. Arcing is prevented in the apparatus by using gas mixtures containing He, which limits ionization, by using high flow velocities, and by properly spacing the rf-powered electrode.
    Type: Grant
    Filed: April 21, 1999
    Date of Patent: July 17, 2001
    Assignee: The Regents of the University of California
    Inventors: Gary S. Selwyn, Ivars Henins, Steve E. Babayan, Robert F. Hicks
  • Patent number: 6262826
    Abstract: An optical system compatible with short wavelength (extreme ultraviolet) radiation comprising four reflective elements for projecting a mask image onto a substrate. The four optical elements are characterized in order from object to image as convex, concave, convex and concave mirrors. The optical system is particularly suited for step and scan lithography methods. The invention increases the slit dimensions associated with ringfield scanning optics, improves wafer throughput and allows higher semiconductor device density.
    Type: Grant
    Filed: January 4, 2000
    Date of Patent: July 17, 2001
    Assignee: The Regents of the University of California
    Inventor: David R. Shafer
  • Patent number: 6262343
    Abstract: Nucleic acid molecules (cDNAs and genes) that confer resistance to the plant pathogen Xanthomonas campestris are disclosed. These molecules may be introduced into plants that are otherwise susceptible to infection by this bacterium in order to enhance resistance.
    Type: Grant
    Filed: July 23, 1999
    Date of Patent: July 17, 2001
    Assignee: The Regents of the University of California
    Inventors: Brian J. Staskawicz, Douglas Dahlbeck, Thomas H. Tai
  • Patent number: 6262495
    Abstract: A two dimensional periodic pattern of capacitive and inductive elements defined in the surface of a metal sheet are provided by a plurality of conductive patches each connected to a conductive back plane sheet between which an insulating dielectric is disposed. The elements acts to suppress surface currents in the surface defined by them. In particular, the array forms a ground plane mesh for use in combination with an antenna. The performance of a ground plane mesh is characterized by a frequency band within which no substantial surface currents are able to propagate along the ground plane mesh. Use of such a ground plane in aircraft or other metallic vehicles thereby prevents radiation from the antenna from propagating along the metallic skin of the aircraft or vehicle. This eliminates surface currents between the antenna and the ground plane thereby reducing power loss and unwanted coupling between neighboring antennae.
    Type: Grant
    Filed: February 23, 1999
    Date of Patent: July 17, 2001
    Assignee: The Regents of the University of California
    Inventors: Eli Yablonovitch, Dan Sievenpiper
  • Patent number: 6261791
    Abstract: The invention provides a novel prostate cell-surface antigen, designated Prostate Stem Cell Antigen (PSCA), which is widely over-expressed across all stages of prostate cancer, bladder cancer and bone metastasis of prostate cancer. Antibodies specific to PSCA are used for diagnosis of these cancers.
    Type: Grant
    Filed: May 25, 1999
    Date of Patent: July 17, 2001
    Assignee: The Regents of the University of California
    Inventors: Robert E. Reiter, Owen N. Witte
  • Patent number: 6261931
    Abstract: A method for growing high-quality gallium nitride over a substrate is disclosed. The method comprises growing first layer with a high dislocation density over the substrate, a second layer having a high number of point defects and a reduced dislocation density as compared to the dislocation density of the first layer over the first layer, and a third layer having a reduced number of point defects as compared to the second layer over the second layer. The resulting gallium nitride is semi-insulating, which inhibits parasitic current flow and parasitic capacitive effects, yet it not so insulating that electron flow in adjacent transistor channels is inhibited.
    Type: Grant
    Filed: June 19, 1998
    Date of Patent: July 17, 2001
    Assignee: The Regents of the University of California
    Inventors: Stacia Keller, Bernd Peter Keller, Umesh Kumar Mishra, Steven P. DenBaars
  • Patent number: 6261760
    Abstract: This invention provides a novel intracellular recycling free cholesterol pathway whose activity is required for cell division. The pathway provides the cholesterol needed for cell division prior to separation of daughter cells (mitosis). The new pathway offers several targets from pharmaceutical intervention, either via small molecules (such as sterol analogs) or by molecular engineering (preventing the cell from accumulating cholesterol by promoting free cholesterol efflux by transfection of caveolin cDNA).
    Type: Grant
    Filed: March 8, 1999
    Date of Patent: July 17, 2001
    Assignee: The Regents of The University of California
    Inventors: Christopher J. Fielding, Phoebe E. Fielding
  • Patent number: 6261484
    Abstract: A method for generating spherical and irregularly shaped dense particles of ceramic oxides having a controlled particle size and particle size distribution. An aerosol containing precursor particles of oxide ceramics is directed into a plasma. As the particles flow through the hot zone of the plasma, they melt, collide, and join to form larger particles. If these larger particles remain in the hot zone, they continue melting and acquire a spherical shape that is retained after they exit the hot zone, cool down, and solidify. If they exit the hot zone before melting completely, their irregular shape persists and agglomerates are produced. The size and size distribution of the dense product particles can be controlled by adjusting several parameters, the most important in the case of powder precursors appears to be the density of powder in the aerosol stream that enters the plasma hot zone.
    Type: Grant
    Filed: August 11, 2000
    Date of Patent: July 17, 2001
    Assignee: The Regents of the University of California
    Inventors: Jonathan Phillips, Seth S. Gleiman, Chun-Ku Chen
  • Patent number: 6262248
    Abstract: Disclosed is substantially pure DNA encoding an Arabidopsis thaliana Rps2 polypeptide; substantially pure Rps2 polypeptide; and methods of using such DNA to express the Rps2 polypeptide in plant cells and whole plants to provide, in transgenic plants, disease resistance to pathogens. Also disclosed are conserved regions characteristic of the RPS family and primers and probes for the identification and isolation of additional RPS disease-resistance genes.
    Type: Grant
    Filed: April 28, 1999
    Date of Patent: July 17, 2001
    Assignees: Massachusetts General Hospital Corporation, The United States of America as represented by the Secretary of Agriculture, Commonwealth Scientific and Industrial Research Organization, The Regents of the University of California
    Inventors: Frederick M. Ausubel, Brian J. Staskawicz, Andrew F. Bent, Douglas Dahlbeck, Fumiaki Katagiri, Barbara N. Kunkel, Michael Nicholas Mindrinos, Guo-Liang Yu, Barbara Baker, Jeffrey Ellis, John Salmeron
  • Patent number: 6258845
    Abstract: Activation of the Ki-ras proto-oncogene is common in colon carcinogenesis. Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit carcinogen-induced colon carcinogenesis, decrease the frequency of Ki-ras mutations in the azoxymethane-treated rat model, and induce apoptosis in a variety of cell types. Sulindac, as well as other non-steroidal anti-inflammatory agents, are provided in combination with DFMO the prevention and/or treatment of cancers characterized by the expression of an activated Ki-ras. Provided with the present invention are pharmaceutically acceptable compositions that include a non-steroidal anti-inflammatory agent, sulindac, together with an effective amount of difluoromethylornithine.
    Type: Grant
    Filed: March 26, 1999
    Date of Patent: July 10, 2001
    Assignees: The Regents of the University of California, Arizonia Board of Regents Behalf of the University of Arizonia
    Inventors: Eugene W Gerner, Frank L. Meyskens, Jr.
  • Patent number: 6258939
    Abstract: The invention provides a novel prostate cell-surface antigen, designated Prostate Stem Cell Antigen (PSCA), which is widely over-expressed across all stages of prostate cancer, including high grade prostatic intraepithelial neoplasia (PIN), androgen-dependent and androgen-independent prostate tumors.
    Type: Grant
    Filed: December 2, 1998
    Date of Patent: July 10, 2001
    Assignee: The Regents of the University of California
    Inventors: Robert E. Reiter, Owen N. Witte
  • Patent number: 6259085
    Abstract: A backside illuminated charge coupled device (CCD) is formed of a relatively thick high resistivity photon sensitive silicon substrate, with frontside electronic circuitry, and an optically transparent backside ohmic contact for applying a backside voltage which is at least sufficient to substantially fully deplete the substrate. A greater bias voltage which overdepletes the substrate may also be applied. One way of applying the bias voltage to the substrate is by physically connecting the voltage source to the ohmic contact. An alternate way of applying the bias voltage to the substrate is to physically connect the voltage source to the frontside of the substrate, at a point outside the depletion region. Thus both frontside and backside contacts can be used for backside biasing to fully deplete the substrate. Also, high resistivity gaps around the CCD channels and electrically floating channel stop regions can be provided in the CCD array around the CCD channels.
    Type: Grant
    Filed: February 15, 2000
    Date of Patent: July 10, 2001
    Assignee: The Regents of the University of California
    Inventor: Stephen Edward Holland
  • Patent number: 6258567
    Abstract: Preparation of 13C/15N-labeled DNA oligomers using the polymerase chain reaction (PCR). A PCR based method for uniform (13C/15N)-labeling of DNA duplexes is described. Multiple copies of a blunt-ended duplex are cloned into a plasmid, each copy containing the sequence of interest and restriction Hinc II sequences at both the 5′ and 3′ ends. PCR using bi-directional primers and uniformly 13C/15N-labeled dNTP precursors generates labeled DNA duplexes containing multiple copies of the sequence of interest. Twenty-four cycles of PCR, followed by restriction and purification, gave the uniformly 13C/15N-labeled duplex sequence with a 30% yield. Such labeled duplexes find significant applications in multinuclear magnetic resonance spectroscopy.
    Type: Grant
    Filed: May 29, 1999
    Date of Patent: July 10, 2001
    Assignee: The Regents of the University of California
    Inventors: Xian Chen, Goutam Gupta, E. Morton Bradbury
  • Patent number: 6258789
    Abstract: Intestinal epithelial cells of a mammalian subject are genetically altered to operatively incorporate a gene which expresses a protein which has a desired effect. The method of the invention comprises administration of a formulation containing DNA to the gastrointestinal tract, preferably by an oral route. The expressed recombinant protein is secreted directly into the bloodstream. Of particular interest is the use of the method of the invention to provide for short term delivery of gene products to the bloodstream.
    Type: Grant
    Filed: June 11, 1999
    Date of Patent: July 10, 2001
    Assignee: The Regents of the University of California
    Inventors: Michael German, Ira D. Goldfine, Stephen S. Rothman
  • Patent number: 6260005
    Abstract: FALCON is a method for automatic multivariable optimization for arbitrary assessment criteria that can be applied to numerous fields where outcome simulation is combined with optimization and assessment criteria. A specific implementation of FALCON is for automatic radiation therapy treatment planning. In this application, FALCON implements dose calculations into the planning process and optimizes available beam delivery modifier parameters to determine the treatment plan that best meets clinical decision-making criteria. FALCON is described in the context of the optimization of external-beam radiation therapy and intensity modulated radiation therapy (IMRT), but the concepts could also be applied to internal (brachytherapy) radiotherapy. The radiation beams could consist of photons or any charged or uncharged particles. The concept of optimizing source distributions can be applied to complex radiography (e.g.
    Type: Grant
    Filed: February 9, 1999
    Date of Patent: July 10, 2001
    Assignee: The Regents of the University of California
    Inventors: Tser-Yuan Yang, Edward I. Moses, Christine Hartmann-Siantar
  • Publication number: 20010006215
    Abstract: Detection of submicron scale cracks and other mechanical and chemical surface anomalies using PET. This surface technique has sufficient sensitivity to detect single voids or pits of sub-millimeter size and single cracks or fissures of millimeter size; and single cracks or fissures of millimeter-scale length, micrometer-scale depth, and nanometer-scale length, micrometer-scale depth, and nanometer-scale width. This technique can also be applied to detect surface regions of differing chemical reactivity. It may be utilized in a scanning or survey mode to simultaneously detect such mechanical or chemical features over large interior or exterior surface areas of parts as large as about 50 cm in diameter. The technique involves exposing a surface to short-lived radioactive gas for a time period, removing the excess gas to leave a partial monolayer, determining the location and shape of the cracks, voids, porous regions, etc., and calculating the width, depth, and length thereof. Detection of 0.
    Type: Application
    Filed: January 4, 1999
    Publication date: July 5, 2001
    Applicant: Regents of the University of California
    Inventors: THOMAS E COWAN, RICHARD H HOWELL, CARLOS A COLMENARES
  • Patent number: 6255012
    Abstract: A thin low-cost bipolar plate for an electrochemical cell is formed from a polymer support plate with first flow channels on a first side of the support plate and second flow channels on a second side of the support plate, where the first flow channels and second flow channels have intersecting locations and have a depth effective to form openings through the support plate at the intersecting locations. A first foil of electrically conductive material is pressed into the first flow channels. A second foil of electrically conductive material pressed into the second flow channels so that electrical contact is made between the first and second foils at the openings through the support plate. A particular application of the bipolar plate is in polymer electrolyte fuel cells.
    Type: Grant
    Filed: November 19, 1999
    Date of Patent: July 3, 2001
    Assignee: The Regents of the University of California
    Inventors: Mahlon S. Wilson, Christine Zawodzinski
  • Patent number: 6255289
    Abstract: Secretory gland cells, particularly pancreatic and salivary gland cells, are genetically altered to operatively incorporate a gene which expresses a protein which has a desired therapeutic effect on a mammalian subject. The expressed protein is secreted directly into the gastrointestinal tract and/or blood stream to obtain therapeutic blood levels of the protein thereby treating the patient in need of the protein. The transformed secretory gland cells provide long term therapeutic cures for diseases associated with a deficiency in a particular protein or which are amenable to treatment by overexpression of a protein.
    Type: Grant
    Filed: August 7, 1998
    Date of Patent: July 3, 2001
    Assignee: The Regents of the University of California
    Inventors: Michael German, Ira D. Goldfine, Stephen S. Rothman
  • Patent number: 6254869
    Abstract: Vaccines, antibodies, proteins, DNAs and RNAs for diagnosis, prophylaxis, treatment and detection of Cryptosporidium species or Cryptosporidium species infections. Cryptosporidium species antigen and DNAs and RNA encoding the Cryptosporidium antigen and fragments thereof and recombinant proteins or fusion proteins produced thereby. Methods for diagnosis, prophylaxis, treatment and detection of Cryptosporidium species infections.
    Type: Grant
    Filed: March 27, 1997
    Date of Patent: July 3, 2001
    Assignee: The Regents of the University of California
    Inventors: Carolyn Petersen, Jin-Xing Huang
  • Patent number: 6255091
    Abstract: A method is presented for determining if the inhibition of metal mediated serine proteases can be potentiated by cobalt or zinc ions.
    Type: Grant
    Filed: November 19, 1996
    Date of Patent: July 3, 2001
    Assignees: AXYS Pharmaceuticals, Inc., The Regents of the University of California
    Inventors: James M. Clark, Kyle Elrod, Thomas E. Jenkins, Bradley A. Katz, William R. Moore, Robert M. Stroud